Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prospects to translate the biology of IL-33 and ST2 during organ transplantation into therapeutics to treat graft-versus-host disease.

Literature DB >> 28149862

Prospects to translate the biology of IL-33 and ST2 during organ transplantation into therapeutics to treat graft-versus-host disease.

Ian C Scott¹, Kirsty F Houslay¹, E Suzanne Cohen¹.

Abstract

Entities: Disease Gene

Year: 2016 PMID： 28149862 PMCID： PMC5233546 DOI： 10.21037/atm.2016.11.74

Source DB: PubMed Journal: Ann Transl Med ISSN： 2305-5839

× No keyword cloud information.

25 in total

1. Generation and characterization of rat anti-mouse ST2L monoclonal antibodies.

Authors: Natalie Fursov; Erin Johnston; Karen Duffy; Adam Cotty; Theodore Petley; Jamie Fisher; Haiyan Jiang; Michael A Rycyzyn; Jill Giles-Komar; Gordon Powers
Journal: Hybridoma (Larchmt) Date: 2011-04

2. IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival.

Authors: Heth R Turnquist; Zhenlin Zhao; Brian R Rosborough; Quan Liu; Antonino Castellaneta; Kumiko Isse; Zhiliang Wang; Megan Lang; Donna Beer Stolz; Xin Xiao Zheng; A Jake Demetris; Foo Y Liew; Kathryn J Wood; Angus W Thomson
Journal: J Immunol Date: 2011-09-26 Impact factor: 5.422

3. The immune-modulating cytokine and endogenous Alarmin interleukin-33 is upregulated in skin exposed to inflammatory UVB radiation.

Authors: Scott Napier Byrne; Clare Beaugie; Clare O'Sullivan; Sarah Leighton; Gary M Halliday
Journal: Am J Pathol Date: 2011-05-13 Impact factor: 4.307

4. Targeting ST2L potentiates CpG-mediated therapeutic effects in a chronic fungal asthma model.

Authors: Hemanth Ramaprakash; Takehiko Shibata; Karen E Duffy; Ugur B Ismailoglu; Rachel M Bredernitz; Ana Paula Moreira; Ana L Coelho; Anuk M Das; Natalie Fursov; Geoffrey L Chupp; Cory M Hogaboam
Journal: Am J Pathol Date: 2011-05-14 Impact factor: 4.307

Review 5. Interleukin 33 is a guardian of barriers and a local alarmin.

Authors: Nikolas T Martin; Michael U Martin
Journal: Nat Immunol Date: 2016-02 Impact factor: 25.606

6. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.

Authors: Gaby Palmer; Brian P Lipsky; Molly D Smithgall; David Meininger; Sophia Siu; Dominique Talabot-Ayer; Cem Gabay; Dirk E Smith
Journal: Cytokine Date: 2008-05-02 Impact factor: 3.861

7. Structural insights into the interaction of IL-33 with its receptors.

Authors: Xi Liu; Michal Hammel; Yanfeng He; John A Tainer; U-Ser Jeng; Linqi Zhang; Shuying Wang; Xinquan Wang
Journal: Proc Natl Acad Sci U S A Date: 2013-08-26 Impact factor: 11.205

8. Deletion of the ST2 proximal promoter disrupts fibroblast-specific expression but does not reduce the amount of soluble ST2 in circulation.

Authors: Brian P Lipsky; Dean Y Toy; David A Swart; Molly D Smithgall; Dirke Smith
Journal: Eur J Immunol Date: 2012-06-12 Impact factor: 5.532

Review 9. Targeting the IL-33/IL-13 Axis for Respiratory Viral Infections.

Authors: Chantal Donovan; Jane E Bourke; Ross Vlahos
Journal: Trends Pharmacol Sci Date: 2016-01-29 Impact factor: 14.819

10. Generation of potent mouse monoclonal antibodies to self-proteins using T-cell epitope "tags".

Authors: Jennifer L Percival-Alwyn; Elizabeth England; Benjamin Kemp; Laura Rapley; Nicola H E Davis; Grant R McCarthy; Jayesh B Majithiya; Dominic J Corkill; Sarah Welsted; Kevin Minton; E Suzanne Cohen; Matthew J Robinson; Claire Dobson; Trevor C I Wilkinson; Tristan J Vaughan; Maria A T Groves; Natalie J Tigue
Journal: MAbs Date: 2015 Impact factor: 5.857

6 in total

1. Computational Cosolvent Mapping Analysis Leads to Identify Salicylic Acid Analogs as Weak Inhibitors of ST2 and IL33 Binding.

Authors: Xinrui Yuan; Krishnapriya Chinnaswamy; Jeanne A Stuckey; Chao-Yie Yang
Journal: J Phys Chem B Date: 2022-03-16 Impact factor: 3.466

Review 2. T_H2 cell development and function.

Authors: Jennifer A Walker; Andrew N J McKenzie
Journal: Nat Rev Immunol Date: 2017-10-30 Impact factor: 53.106

3. A helminth-derived suppressor of ST2 blocks allergic responses.

Authors: Francesco Vacca; Caroline Chauché; Abhishek Jamwal; Elizabeth C Hinchy; Graham Heieis; Holly Webster; Adefunke Ogunkanbi; Zala Sekne; William F Gregory; Martin Wear; Georgia Perona-Wright; Matthew K Higgins; Josquin A Nys; E Suzanne Cohen; Henry J McSorley
Journal: Elife Date: 2020-05-18 Impact factor: 8.140

Prospects to translate the biology of IL-33 and ST2 during organ transplantation into therapeutics to treat graft-versus-host disease.

1. Generation and characterization of rat anti-mouse ST2L monoclonal antibodies.

2. IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival.

3. The immune-modulating cytokine and endogenous Alarmin interleukin-33 is upregulated in skin exposed to inflammatory UVB radiation.

4. Targeting ST2L potentiates CpG-mediated therapeutic effects in a chronic fungal asthma model.

Review 5. Interleukin 33 is a guardian of barriers and a local alarmin.

6. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.

7. Structural insights into the interaction of IL-33 with its receptors.

8. Deletion of the ST2 proximal promoter disrupts fibroblast-specific expression but does not reduce the amount of soluble ST2 in circulation.

Review 9. Targeting the IL-33/IL-13 Axis for Respiratory Viral Infections.

10. Generation of potent mouse monoclonal antibodies to self-proteins using T-cell epitope "tags".

1. Computational Cosolvent Mapping Analysis Leads to Identify Salicylic Acid Analogs as Weak Inhibitors of ST2 and IL33 Binding.

Review 2. T_H2 cell development and function.

3. A helminth-derived suppressor of ST2 blocks allergic responses.

Review 4. Role of Mast Cells and Type 2 Innate Lymphoid (ILC2) Cells in Lung Transplantation.

Review 5. Stem Cell Therapy and Innate Lymphoid Cells.

Review 6. Lipid-mediated innate lymphoid cell recruitment and activation in aspirin-exacerbated respiratory disease.

Review 5. Interleukin 33 is a guardian of barriers and a local alarmin.

Review 9. Targeting the IL-33/IL-13 Axis for Respiratory Viral Infections.

Review 2. TH2 cell development and function.

Review 4. Role of Mast Cells and Type 2 Innate Lymphoid (ILC2) Cells in Lung Transplantation.

Review 5. Stem Cell Therapy and Innate Lymphoid Cells.

Review 6. Lipid-mediated innate lymphoid cell recruitment and activation in aspirin-exacerbated respiratory disease.

Review 2. T_H2 cell development and function.